Neuropeptide Y receptor blockage: A treatment for many ills?
Previously, Dr. Herzog and colleagues found that blockade of the neuropeptide Y1 receptor also increases bone mass in mice.
“It’s a modest effect, but there’s nothing out there at the moment that really improves bone mass. If you can stop osteoporosis, that’s a benefit on its own,” he said.
Now they hope to study BIBO’s vasodilatory properties as a potential treatment for hypertension, if they get the funding.
Dr. Herzog is hopeful, as obesity, osteoporosis, and hypertension are all chronic conditions. “Having one drug that benefits them all would surely be of interest to clinicians and drug companies,” he observed.
Dr. Yan and Dr. Herzog have reported no relevant financial relationships.
A version of this article first appeared on Medscape.com.